Why don’t people have kidneydialysis at home? NIHR Evidence - Why don’t people have kidneydialysis at home? - NIHR Evidence - Informative and accessible health and care researchWhy don’t people have kidneydialysis at home? - NIHR Evidence * * Evidence * About Us * Browse content * Brain and Nerves * Birth Conditions * Blood * Cancer * Heart and Circulation * Dementia content * About Us * Glossary * Contact us * Site map * Cookies * Homepage * > * Alert * > * Why don’t people have kidneydialysis at home?Why don’t people have kidneydialysis at home?Kidneys and the Urogenital System10.08.22doi: 10.3310/nihrevidence_52322View commentaries on this research This is a plain English summary of an original research articlePeople with kidney disease described why
The Infant KIdneyDialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant He Renal replacement therapy (RRT) options are limited for small babies because of lack of available technology. We investigated the precision
The utilization of renaldialysis: a comprehensive study in Saudi Arabia. Understanding the trend of utilization of renaldialysis in Saudi Arabia (SA) is fundamental as it provides a general overview of renal care. The practice of renaldialysis assists in identifying challenges, opportunities, and potential areas for improvement in the provision of the services. This research investigated the utilization of renaldialysis services in SA by exploring the number of renaldialysis centers, hemodialysis machines (HD), and peritoneodialysis patients. The dataset for this study was derived from a collaboration between the General Authority of Statistics (GaStat) and the Ministry of Health (MoH), focusing on indicators for renaldialysis centers and patients across health sectors in 2021. Analysis
Regional anaesthesia could improve fistula function for kidneydialysis Regional anaesthesia could improve fistula function for kidney dialysisRegional anaesthesia could improve fistula function for kidneydialysis Skip to content * Accessibility options: * * Search articles Evidence * About Us * Browse content * Brain and Nerves * Birth Conditions * Blood * Cancer * Heart and Circulation and FundingBibliographyMenu * About Us * Browse content * Become a reviewer * Newsletter Sign Up * Contact us * Homepage * > * Alert * > * Regional anaesthesia could improve fistula function for kidneydialysis Regional anaesthesia could improve fistula function for kidney dialysisKidneys and the Urogenital System 25.07.17 doi: 10.3310/signal-000454 View commentaries on this research Please note that this summary
Home-based KidneyDialysis versus In-center or Other Outpatient KidneyDialysis Locations Management Briefs eBrief-no98 -- skip to page content Talk to the Veterans Crisis Line now An official website of the United States government Here's how you know The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're ..
A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renaldialysis patients: Preliminary report. Patients with end-stage renal disease (ESRD) on hemodialysis (HD) are considered particularly susceptible to infection with SARS-CoV2 on the basis of the immunodeficiency associated with advanced age, comorbidity burden, medication use, and need for frequent visits
KidneyDialysisKidneydialysis treatment options | Kidney Research UK | Patient * TOPICS * HEALTH INFO * Child Health * Heart Health * Men's Health * Mental Health * Pregnancy * Sexual Health * Skin Conditions * Travel Vaccinations * Treatment and Medication * Women's Health * View all categories * CATEGORIES * Bones Medical Professional? * Community * * Login / Register * * Login / Register * Patient Access . Search 1. Health Info 2. Chronic Kidney Disease (CKD) 3. Features * Save Saved * Print * Actions * Send Feedback * Manage Notes Kidneydialysis treatment optionsAuthored by Kidney Research UKReviewed by Dr Hayley WillacyKidney Research UK has published
Effect of renaldialysis on mortality and complications following hip fracture surgery in elderly patients: A population based retrospective cohort study. Hip fractures in older patients requiring dialysis are associated with high mortality. The primary aim of this study was to evaluate the specific burden of dialysis on 30-day mortality following hip fracture surgery. The secondary aim
Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renaldialysis patients: effect on muscle strength and quality of life. The importance of vitamin D sufficiency in deficient dialysis patients is uncertain. This study aimed to determine if high-dose cholecalciferol for 1-year affected symptoms, muscle strength, blood pressure (BP), cardiac ischaemia, parathyroid
Predictors of late presentation to renaldialysis: a cohort study of linked primary and secondary care records in East London. The outcomes and experience of care for patients who start renal replacement therapy (RRT) in an unplanned manner are worse than for those who have planned care. The objective of this study was to examine the primary care predictors of unplanned starts to RRT
Long-Term Single Centre Outcomes of Patients with Chronic RenalDialysis Undergoing Cardiac Surgery. The prevalence of dialysis-dependent chronic renal failure (DD-CRF) is growing worldwide. Such patients are exposed to a higher cardiovascular risk because of severe calcification and congestive heart failure caused by volume overload, with poor outcomes. This study aimed to evaluate outcomes
Intravascular Renal Denervation in RenalDialysis Patients with Uncontrolled Hypertension: A Case Series of Four Patients BACKGROUND Hypertension is a common complication of renaldialysis and is inadequately controlled in approximately one-third of patients. Intravascular renal denervation is an option to control sympathetic overdrive and decrease blood pressure. Four renaldialysis patients are presented with uncontrolled hypertension who were treated with intravascular renal denervation. CASE REPORT In a renaldialysis unit, patients were screened for therapy-resistant hypertension, which was defined as an outpatient blood pressure >160/100 mmHg and a blood pressure by interdialytic ambulatory blood pressure monitoring (ABPM) >130/80 mmHg. Four patients were identified with a mean ABPM of 175
Renaldialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis Renal disease is considered the main cause of natural mortality in dogs with canine leishmaniosis. The pathological mechanisms associated with kidney injury in canine leishmaniosis include immune complex glomerulonephritis, tubulointerstitial nephritis and occasionally renal amyloidosis
Development and effect of a rational-emotive-behaviour-therapy-based self-management programme for early renaldialysis patients. This study attempts to develop and determine the effect a rational-emotive-behaviour-therapy-based self-management programme can have on the self-efficacy, self-care, depression and dyssomnia of patients undergoing early renaldialysis. When renaldialysis is initiated, changes in everyday life are inevitable, and patients can suffer from both psychological and physical symptoms. Hence, to obtain the best results from renaldialysis, active self-management is required. Quasi-experimental and longitudinal. Forty-eight early-stage renaldialysis patients registered for and undergoing renaldialysis at a hospital located in S city participated in this study
The influence of renaldialysis and hip fracture sites on the 10-year mortality of elderly hip fracture patients: A nationwide population-based observational study. Hip fractures in older people requiring dialysis are associated with high mortality. Our study primarily aimed to evaluate the specific burden of dialysis on the mortality rate following hip fracture. The secondary aim was to clarify
Cryptococcosis in HIV-negative Patients with RenalDialysis: A Retrospective Analysis of Pooled Cases Cryptococcosis is a lethal fungal infection mainly caused by Cryptococcus neoformans/C. gattii species. Currently, our understanding of cryptococcosis episodes in HIV-negative patients during renaldialysis remains scarce and fragmented. Here, we performed an analysis of pooled cases to systemically summarize the epidemiology and clinical characteristics of cryptococcosis among HIV-negative patients with renaldialysis. Using pooled data from our hospital and studies identified in four medical databases, 18 cases were identified and analyzed. The median duration time of renaldialysis for peritoneal renaldialysis and hemodialysis cases was 8 months and 36 months, respectively. Several non
Captivating a captive audience: a quality improvement project increasing participation in intradialytic exercise across five renaldialysis units Benefits of exercise on dialysis (EOD) are well established, however, uptake in our local satellite haemodialysis units is low. The implications of the status quo are risks to treatment efficiency, equity and patient centredness in managing personal
Correlates of symptom burden in renaldialysis patients: a systematic review and meta-analysis PROSPEROInternational prospective register of systematic reviews Print | PDFPROSPEROThis information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied
Optimum dosing of amikacin in critically ill patients undergoing renal-dialysis, hemofiltration and ECMO: protocol of a Systematic review PROSPEROInternational prospective register of systematic reviews Print | PDFOptimum dosing of amikacin in critically ill patients undergoing renal-dialysis, hemofiltration and ECMO: protocol of a Systematic reviewShahriar Shahsavar-Mistani, Elahe Karimpour registration. Further detail is provided here.CitationShahriar Shahsavar-Mistani, Elahe Karimpour-Razkenari, Mojtaba Mojtahedzadeh, Atabak Najafi. Optimum dosing of amikacin in critically ill patients undergoing renal-dialysis, hemofiltration and ECMO: protocol of a Systematic review. PROSPERO 2024 CRD42024513958 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024513958Review